NF-κB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program

Activation of the transcription factor NF-κB is critical for the tumor necrosis factor-α (TNF-α)-induced inflammatory response. Here we report the complete gene expression profile from activated microvascular endothelial cells emphasizing the direct contribution of the NF-κB pathway. Human microvasc...

Full description

Saved in:
Bibliographic Details
Published inNucleic acids research Vol. 33; no. 16; pp. 5308 - 5319
Main Authors Kempe, Sybille, Kestler, Hans, Lasar, Andrea, Wirth, Thomas
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.01.2005
Oxford Publishing Limited (England)
Online AccessGet full text

Cover

Loading…
More Information
Summary:Activation of the transcription factor NF-κB is critical for the tumor necrosis factor-α (TNF-α)-induced inflammatory response. Here we report the complete gene expression profile from activated microvascular endothelial cells emphasizing the direct contribution of the NF-κB pathway. Human microvascular endothelial cell line-1 (HMEC-1) cells were modified to express dominant interfering mutants of the IKK/NF-κB signaling module and expression profiles were determined. Our results provide compelling evidence for the virtually absolute dependence of TNF-α-regulated genes on NF-κB. A constitutively active IKK2 was sufficient for maximal induction of most target genes, whereas a transdominant IκBα suppressed gene expression. Several genes with a critical role in atherogenesis were identified. The endothelial lipase (EL) gene, a key enzyme involved in lipoprotein metabolism, was investigated more in detail. Binding sites interacting with NF-κB in vitro and in vivo were identified and co-transfection experiments demonstrated the direct regulation of the EL promoter by NF-κB. We conclude that targeting the IKK/NF-κB pathway or specific genes downstream may be effective for the control or prevention of chronic inflammatory diseases such as atherosclerosis.
Bibliography:istex:90802FA5E4C4C7A63106612EC1BB5D749540D773
local:gki836
ark:/67375/HXZ-9PH8FL8B-R
To whom correspondence should be addressed. Tel: +49 0 731 502 3270; Fax: +49 0 731 502 2892; Email: thomas.wirth@medizin.uni-ulm.de
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0305-1048
1362-4962
DOI:10.1093/nar/gki836